3 hours agoThe medicine produced by this plant can be the next treatment for treating the coronary
Periskopi(5 years ago)
(5 years ago)An antiviral drug derived from the plant called Thaspia can be very effective in treating the coronavirus ʹ and can also help in the fight against future pandemics, according to the new study in the United Kingdom. Researchers at Nottingham University discovered that the vast spectrum of antiviral sepsigargin is not just [...]
An antiviral drug derived from the plant called Thaspia can be very effective in treating the coronavirus ʹ and can also help in the fight against future pandemics, according to the new study in the United Kingdom.
Researchers at Nottingham UniversityThey found that the wide spectrum of antiviral thapsigargin is not only very effective against COVIED-19, but also against a common cold coronary called the syncitial respiratory virus and flu A, Eurekalert reported.org.
“While we are still in the early stages of research on this antivirus and its impact on how to treat viruses such as COVID-19, these findings are extremely important”, said Professor Kin-Chow Chang, who conducted the study together with colleagues at the Animal Health and Plant Agency, China Agricultural University and the Pirbrate Institute.
The current “Pandemia stresses the need for effective antivirus to deal with active infections, as well as vaccines, to prevent infection,” he said. Keeping in mind that future pandemics are likely of animal origin, where animals occur in human and one-on-one (man in animals), a new generation of antivirals, such as thapsigargin, can play a key role in controlling and treating important viral infections in both humans and animals”, Chang added.
Scientists found that antivirus, in small doses, causes an immune response “very effective” against the three major types of human respiratory viruses, including COVID-19.
Thapsigargin, which has been tested for prostate cancer, is effective against viral infection when used before or during active infection, according to the study.
It is able to prevent a virus from making new copies of itself in cells for at least 48 hours after a mere 30 - minute exposure, according to the study.
“Although more testing is needed, current findings strongly show that thapsigargin and its derivatives are promising antiviral treatments against COVID-19 and the flu virus have the potential to protect us against the next pandemic of X”, Chang said.
